Old Web
English
Sign In
Acemap
>
Paper
>
[New drug approval: Dostarlimab - second line in advanced MSI endometrial cancer].
[New drug approval: Dostarlimab - second line in advanced MSI endometrial cancer].
2021
Maxime Galienne
Manuel Rodrigues
Keywords:
second line
Internal medicine
drug approval
Oncology
Endometrial cancer
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
2
Citations
NaN
KQI
[]